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Strong and sustainable primary 
healthcare is associated 
with a lower risk of hospitalization 
in high risk patients
Olga A. Sawicki1*, Angelina Mueller1, Renate Klaaßen‑Mielke2, Anastasiya Glushan1, 
Ferdinand M. Gerlach1, Martin Beyer1, Michel Wensing3 & Kateryna Karimova1
In 2004, Germany introduced a program based on voluntary contracting to strengthen the role of 
general practice care in the healthcare system. Key components include structured management 
of chronic diseases, coordinated access to secondary care, data‑driven quality improvement, 
computerized clinical decision‑support, and capitation‑based reimbursement. Our aim was to 
determine the long‑term effects of this program on the risk of hospitalization of specific categories 
of high‑risk patients. Based on insurance claims data, we conducted a longitudinal observational 
study from 2011 to 2018 in Baden‑Wuerttemberg, Germany. Patients were assigned to one or more 
of four open cohorts (in 2011, elderly, n = 575,363; diabetes mellitus, n = 163,709; chronic heart 
failure, n = 82,513; coronary heart disease, n = 125,758). Adjusted for key patient characteristics, 
logistic regression models were used to compare the hospitalization risk of the enrolled patients 
(intervention group) with patients receiving usual primary care (control group). At the start of the 
study and throughout long‑term follow‑up, enrolled patients in the four cohorts had a lower risk of 
all‑cause hospitalization and ambulatory, care‑sensitive hospitalization. Among patients with chronic 
heart failure and coronary heart disease, the program was associated with significantly reduced risk of 
cardiovascular‑related hospitalizations across the eight observed years. The effect of the program also 
increased over time. Over the longer term, the results indicate that strengthening primary care could 
be associated with a substantial reduction in hospital utilization among high‑risk patients.
Strong primary care, defined as coordinated, comprehensive first-contact  care1, is the cornerstone of the health-
care system and associated with a better functioning health  system2. The benefits of well-developed primary 
care systems are confirmed. Systematic literature reviews reported on mortality reduction, improved population 
health outcomes, and lower healthcare costs associated with strong primary  care3–5. Despite the great recogni-
tion of its impact and the importance to health  systems6, there have been limited restructuring efforts focused 
on primary care services.
In Germany, the fragmentation of care, especially in the ambulatory care  sector7, is a source of increasing 
concern. Registration with a general practitioner (GP) is not mandatory, and usual care entails no formal gate-
keeping procedure. Fragmentation has led to poor continuity of care, redundant services, unnecessary risks, 
and higher  costs8. In 2004, the primary healthcare system in Germany was reorganized through the creation 
of a legal framework aiming to strengthen primary care. In the federal state of Baden-Wuerttemberg, where 
the program was implemented, the GP is the gatekeeper responsible for the coordination of care. The program 
consists of structured management of chronic diseases, continuous data-based quality improvement using com-
puterized decision support for prescribing medication, and payment mainly by capitation per enrolled  patient9. 
The program was expected to improve long-term health  outcomes10–12. Previous studies have shown the program 
to have beneficial effects in terms of hospitalization rates, cost, and 5-year mortality, in the total participant 
 population9,13. Adverse clinical outcomes for patients with both diabetes mellitus and cardiac conditions also 
improved, compared to usual  care14,15. Detailed insights into the reasons behind these effects are limited. As an 
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analysis focusing on chronic disease suggests health service use among high-need patients tends to  decline15, we 
hypothesized that the impact would be highest in patients at high risk of disease  deterioration10,16,17. The aim of 
this study was to assess the long-term effects of the primary care program on hospitalization risk among high-
risk patients over a considerably longer follow-up of eight years. Since the impact of demographic change on 
healthcare systems is a pressing issue in all developed  countries18, it is widely recommended that the long-term 
effects of interventions in high-risk patients are studied before setting health policy.
Results
Characteristics of patients. In 2011, 638,452 patients were included and assigned to one or several of 
the four cohorts: elderly, diabetes, chronic heart failure (CHF), and/or coronary heart disease (CHD). Of those, 
51.4% received care under the primary care program and 48.6% received usual care. Table 1 summarizes the 
number and percentage of included patients by year. Demographic and clinical characteristics of included 
patients by cohort are shown in Table 2. Patients enrolled in the primary care program had more comorbidities 
than non-enrolled patients, as measured using the Charlson index.
Hospitalization in the elderly. Table 3 presents the results of the longitudinal analysis. At the start of the 
study, elderly patients in the intervention group had a significantly lower risk of all-cause hospitalization [Odds 
Ratio (OR): 0.908; 95% CI: 0.900–0.916; Fig. 1] and ambulatory, care-sensitive hospitalizations (ACSH) (OR 
0.900; 95% CI: 0.882–0.919; see Supplementary Fig. S1 online). Whereas the estimated proportions displayed a 
significant downward trend in the control group, the magnitude of the intervention effect increased throughout 
follow-up. Hip fracture-related hospitalization risk was significantly lower in the intervention group at the start 
of the study (OR: 0.943; 95% CI: 0.905–0.983), with no significant difference in the trend between groups over 
the eight-year period (see Supplementary Fig. S2 online). Older patients had increased risk of hospitalization 
as did patients with greater Charlson index score, and comorbidities such as renal failure, hypertension, COPD, 
dementia, and depression.
Hospitalization in diabetics. At the start of the study and throughout the long-term follow-up, enrolled 
patients with diabetes mellitus had a lower risk of all-cause hospitalization (OR 0.949; 95% CI: 0.935–0.964; 
Fig. 2) and ACSH (OR 0.943; 95% CI: 0.914–0.974; see Supplementary Fig. S3 online). A decreasing trend was 
observed in the control group over time. The effect of the program increased over time, while it remained stable 
for diabetes-related hospitalizations (see Supplementary Fig. S4 online). Factors associated with increased risk 
of hospitalization were previous hospitalization, greater Charlson index score as well as the presence of renal 
failure and hypertension.
Hospitalization in patients with cardiovascular diseases. At the start of the study, enrolled CHF and 
CHD patients had had significantly fewer all-cause (CHF OR 0.980; 95% CI: 0.960–0.999; CHD OR 0.962; 95% 
CI: 0.946–0.979; Figs. 3,4) and cardiovascular-related hospitalizations (CHF OR 0.925; 95% CI: 0.901–0.949; 
CHD OR 0.921; 95% CI: 0.901–0.942; see Supplementary Fig. S5–6 online). While the estimated proportion 
of inpatients followed a downward trend in the control group, the effect of the program increased. Among the 
two cardiovascular diseases cohorts, the intervention effect on ACSH was not significant at the start of the study 
but grew in magnitude over the eight-year period and became significant by the end (CHF OR 0.975; 95% CI: 
0.969–0.981; CHD OR 0.978; 95% CI: 0.973–0.983; see Supplementary Fig. S7–8 online). Having a greater Charl-
son index score, renal failure, and hypertension was associated with a higher risk to be hospitalized; similarly 
to previous hospitalization. In contrast, participation in disease management program (DMP) for diabetes was 
protective against hospitalization.
Discussion
This study of routine healthcare revealed a correlation between stronger primary care and a substantial decline 
in hospitalization risk among elderly multi-morbid patients. Both at the start of the study and throughout the 
follow-up, we found that high-risk patients that were enrolled in the program had a lower risk of hospitaliza-
tion. Furthermore, although we observed a downward trend in the estimated proportions of inpatients in both 
Table 1.  Number and percentage of included patients.
Year under observation Usual care, number (%) Primary care program, number (%) Overall, number
2011 310,029 (48.6) 328,423 (51.4) 638,452
2012 312,862 (46.9) 354,369 (53.1) 667,231
2013 300,131 (44.0) 382,097 (56.0) 682,228
2014 283,597 (41.4) 401,003 (58.6) 684,600
2015 282,049 (39.0) 440,661 (61.0) 722,710
2016 274,819 (38.0) 449,133 (62.0) 723,952
2017 269,538 (36.9) 461,465 (63.1) 731,003
2018 260,932 (35.8) 467,860 (64.2) 728,792
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intervention and control groups over the eight-year period, the intervention effect increased over the years, 
although not for hip-fracture and diabetic-related hospitalizations. It thus could be plausible that the increasing 
difference between the groups reflects the sustainable effect of the primary care program. The general downward 
trend observed in hospitalization may be the result of improved quality of care and the wider use of outpatient 
diagnostics and  therapy19.
The impact is higher in high-risk patients than the overall population that was evaluated earlier on in the 
 programme20. At baseline in 2011, the total participant population showed a 10.7% reduction in hospital 
 admissions20. In our study, the risk of hospitalization during the same year was up to 16.4% lower among enrolled 
high-risk patients. Such a difference is likely to be important for both patients and healthcare providers. The 
long-term benefit of the program was greatest among CHF and CHD patients. The study finding that elevated 
risk of hospitalization among high-risk patients was consistently associated with greater Charlson index score, 
renal failure, and hypertension, has been described in previous  studies21–24.
In elderly patients, the study showed that strong primary care could have a substantial and positive impact on 
hospitalization risk for ambulatory care-sensitive conditions (ACSC) but did not lead to any long-term decline 
in hip fracture-related hospitalization. Possible explanations are that the assessed patients were too healthy, or 
that comprehensive geriatric assessments in outpatient settings are ineffective. Numerous studies have indicated 
that the benefits of outpatient-based geriatric assessments are limited in comparison to hospital or rehabilitation 
unit  models25,26. Nevertheless, improved rates of ACSC admissions in enrolled patients may be partially due 
to an emphasis on the core coordinating functions of primary care. The program delivers medical care that is 
based on recommended standards, and trained practice assistants work in concert with the GP and specialists 
to coordinate services across the entire care continuum. Moreover, in pursuit of judicious drug use and high-
quality drug management, GPs regularly participate in pharmacotherapy peer-group training sessions, and use 
electronic decision support when prescribing medications.
In diabetes patients, an improvement in overall hospitalization risk was observed. However, the lack of any 
association between program- and diabetes-related hospitalization over time is worthy of note. It is possible that 
Table 2.  Characteristics of patients by group in two of the final three quarters of 2011. CHF chronic heart 
failure, CHD coronary heart disease, COPD chronic obstructive pulmonary disease, DMP disease management 
program, DM diabetes mellitus, SD standard deviation. *Doctors working in a group practice.
Characteristics


















patients 282,228 293,135 72,480 91,229 38,551 43,962 57,666 68,092
Socio-economic parameter
Mean age, years 
(SD) 76.3 (7.3) 75.7 (6.8)  > 0.001 71.5 (11.3) 70.8 (11.2)  > 0.001 78.2 (10.3) 77.1 (10.0)  > 0.001 74.3 (10.4) 73.7 (10.2)  > 0.001
Sex, % women 61.3 59.6  > 0.001 54.4 53.4  > 0.001 61.9 58.7  > 0.001 44.3 42.7  > 0.001
Need for nurs-
ing, % 17.4 12.7  > 0.001 15.6 11.8  > 0.001 30.0 23.3  > 0.001 16.4 13.1  > 0.001
Rural practice, 
% 48.5 46.0  > 0.001 49.9 47.7  > 0.001 45.6 44.0  > 0.001 50.7 48.0  > 0.001
Group practice* 36.0 47.7  > 0.001 38.1 48.5  > 0.001 36.3 46.6  > 0.001 37.5 47.6  > 0.001
Health service utilization, %
DMP CHD 5.7 11.7  > 0.001 8.5 15.3  > 0.001 11.7 23.6  > 0.001 28.2 53.4  > 0.001
DMP DM 15.1 25.3  > 0.001 54.0 77.9  > 0.001 20.5 33.2  > 0.001 22.8 34.8  > 0.001
Hospital admis-




2.1 (2.2) 2.2 (2.2)  > 0.001 3.3 (2.3) 3.4 (2.3)  > 0.001 3.6 (2.5) 3.7 (2.5)  > 0.001 3.0 (2.5) 3.1 (2.5)  > 0.001
Comorbid condition, %
Renal failure 7.8 8.0 0.005 11.3 10.9 0.003 17.9 17.8 0.6 13.5 13.4 0.542
COPD 9.0 10.2  > 0.001 10.3 11.3  > 0.001 15.6 17.3  > 0.001 13.3 14.7  > 0.001
Dementia 7.8 5.7  > 0.001 5.8 4.5  > 0.001 10.3 8.2  > 0.001 6.3 5.1  > 0.001
Depression 15.1 14.3  > 0.001 16.5 15.6  > 0.001 19.3 17.6  > 0.001 17.2 15.6  > 0.001
Cardiovascular history, %
CHD 16.9 19.1 0.001 24.0 24.8  > 0.001 38.7 41.8  > 0.001 100.0 100.0 n.a
CHF 12.3 13.4  > 0.001 17.0 16.9 0.834 100.0 100.0 n.a 25.9 27.0  > 0.001
Myocardial 
infarction 0.8 0.7 0.033 1.0 0.9 0.137 1.3 1.1 0.119 1.5 1.4 0.115
Hypertension 68.3 70.5  > 0.001 78.1 77.8 0.219 75.9 77.1  > 0.001 78.6 78.8 0.285
Atrial fibril-
lation 8.9 9.4  > 0.001 11.6 10.8  > 0.001 26.9 26.4 0.082 16.9 16.3 0.004
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improvements in diabetes care are more difficult to achieve due to the overall high quality of usual  care27. Diabetes 
has benefitted from DMP for more than two decades in southern  Germany28, and the German diabetes-DMP 
has been particularly successful in implementing comprehensive care, which has also led to high participation 
rates outside the present  programme29.
In CHF and CHD patients, the results suggest that strong primary care has considerable potential to reduce 
hospitalization risk. The impact of the program is remarkably high in comparison to usual care. Since hospital 
admissions for both cardiovascular diseases are sensitive to strong primary care, these findings may be explained 
by suboptimal usual care. As the DMP for CHF was initiated only one year ago, evidence on the effectiveness of 
this program is still lacking. Current adoption patterns of the DMP for CHD may have encouraged relatively weak 
 implementation30. Overall, our study implied that strong primary care appears to be associated with a substantial 
reduction in the hospital utilization of high-risk patients over the longer term. The program delivered structured 
management of chronic diseases, and provided additional incentives for specially trained practice assistants to 
help coordinate care, as it might have improved the quality of treatment and clinical outcomes of  patients31. 
Furthermore, as participating GPs met specific quality requirements, e.g. they based necessary adjustments on 
Table 3.  Hospitalization per year and patient: Odds ratios* based on the longitudinal analysis (2011–2018). 
P-values relate to adjusted effect estimates in generalized linear models based on a longitudinal analysis from 
2011 to 2018. ACSH, ambulatory, care-sensitive hospitalization. CVD cardiovascular disease, OR odds ratio. 
*Odds ratios for all covariates and outcome measures are shown online in the Supplementary Table S2–13.
Intervention group versus control 
group (intervention effect) at the 
start of the study, OR (95% CI) p-value
Control group per year (time 
trend), OR (95% CI) P-value
Time trend in the intervention 
group versus time trend in the 
control group, OR (95% CI) P-value
Elderly
Hospitalization 0.908 (0.900–0.916)  < 0.0001 0.973 (0.971–0.974)  < 0.0001 0.981 (0.979–0.983)  < 0.0001
ACSH 0.900 (0.882–0.919)  < 0.0001 0.978 (0.974–0.981)  < 0.0001 0.986 (0.981–0.990)  < 0.0001
Hospitalization for hip fracture 0.943 (0.905–0.983) 0.0055 0.984 (0.977–0.991)  < 0.0001 0.992 (0.982–1.002) 0.1046
Diabetes mellitus type 2
Hospitalization 0.949 (0.935–0.964)  < 0.0001 0.969 (0.966–0.971)  < 0.0001 0.983 (0.980–0.987)  < 0.0001
ACSH 0.943 (0.914–0.974) 0.0004 0.971 (0.966–0.976)  < 0.0001 0.984 (0.977–0.991)  < 0.0001
Diabetes-related hospitalization 0.833 (0.794–0.874)  < 0.0001 0.934 (0.926–0.942)  < 0.0001 0.996 (0.985–1.007) 0.4610
Chronic heart failure
Hospitalization 0.980 (0.960–0.999) 0.0409 0.970 (0.966–0.973)  < 0.0001 0.975 (0.971–0.979)  < 0.0001
ACSH 0.978 (0.941–1.017) 0.2638 0.987 (0.980–0.994) 0.0001 0.970 (0.961–0.978)  < 0.0001
CVD-related hospitalization 0.925 (0.901–0.949)  < 0.0001 0.962 (0.957–0.966)  < 0.0001 0.975 (0.969–0.981)  < 0.0001
Coronary heart disease
Hospitalization 0.962 (0.946–0.979)  < 0.0001 0.969 (0.966–0.972)  < 0.0001 0.983 (0.979–0.986)  < 0.0001
ACSH 0.970 (0.936–1.005) 0.0969 0.983 (0.977–0.989)  < 0.0001 0.984 (0.976–0.992)  < 0.0001
CVD-related hospitalization 0.921 (0.901–0.942)  < 0.0001 0.965 (0.961–0.969)  < 0.0001 0.978 (0.973–0.983)  < 0.0001
Figure 1.  Estimated proportions of all-cause hospitalization in the elderly, based on generalized linear models 
of the 2011–2018 longitudinal analysis.
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Figure 2.  Estimated proportions of all-cause hospitalization in diabetics, based on generalized linear models of 
the 2011–2018 longitudinal analysis.
Figure 3.  Estimated proportions of all-cause hospitalization in CHF patients, based on generalized linear 
models of the longitudinal analysis from 2011 to 2018.
Figure 4.  Estimated proportions of all-cause hospitalization in CHD patients, based on generalized linear 
models of the longitudinal analysis from 2011 to 2018.
6
Vol:.(1234567890)
Scientific Reports |         (2021) 11:4349  | https://doi.org/10.1038/s41598-021-83962-y
www.nature.com/scientificreports/
a data-driven improvement system, used computerized clinical decision-support, and regularly participated in 
peer-group training sessions, they probably had greater expertise than those providing usual care. Although our 
results do not enable the identification of a key factor responsible for reducing hospitalization, the primary care 
structure in southern Germany permits the delivery of high-quality chronic care. In the United States, patient-
centered medical homes have been identified as a potential means of supporting primary care  delivery5,32. The 
patient-centered medical home has many elements of strong primary care and its implementation is associated 
with improved chronic disease  care33, as well as reduced hospital and emergency department  use34. Our results 
in a healthcare system that faces similar challenges to that in the United States support these findings.
The study has strengths and limitations. The evaluation of the sustained program took place in a real-world 
healthcare setting. The study benefitted from a large cross-sectoral dataset, and advanced statistical modelling. 
The follow-up period was also considerably longer than in any prior study evaluating the primary care program 
in southern Germany. Furthermore, we assessed the effect on hospitalization of different categories of high-risk 
patients. Another strength of the study is the comparison with control groups receiving usual care, and not 
simply with patients that had not enrolled in the program. The samples were therefore highly representative of 
patients that actually require healthcare.
The study also has limitations in terms of data analysis and selection bias. Like many studies based on second-
ary data analysis, we were reliant on data quality (e.g., correct coding), and in our case insurance claims data. 
Clinical information (e.g., diagnostic and prognostic information such as tobacco use) and social economic 
data were not available for adjustment purposes, which may have led to some residual confounding. Moreover, 
our methodical approach together with the lack of randomization excludes causal inference and therefore our 
results need to be interpreted with caution. When the program began, the proportion of hospitalized patients 
in the intervention groups was lower than in the control group. This may have led to an over-estimation of the 
program’s effect. Finally, since participation in the program is voluntary, it may have been influenced by patient 
and physician self-selection, as GPs and patients that chose to participate in the program voluntarily may have 
been more likely to take part in structured management programs, and receive guideline-directed therapies. 
Hence, it cannot be ruled out that the GPs bore greater responsibility for the identified effects than the program. 
Randomized controlled trials evaluating this program are needed. As fragmentation in the delivery of care 
accelerates, strengthening primary care would appear to be a viable means of reducing hospital utilization in 
elderly patients with multiple chronic conditions. Although implementation can be challenging, primary care 
should be strengthened in many other health systems.
Methods
Study design. The study was based on claims data. We used a comparative observational design with a 
follow-up of eight years. Open cohorts were analyzed, which means that all eligible patients of a given year 
were considered, so that the composition of the cohorts changed over the years and repeated measurement per 
subject was possible. Patients enrolled in the primary care program (intervention group) were compared with 
patients that were receiving usual care from a GP that did not participate in it (control group). Both groups were 
from the same geographical area in Germany. Baden-Wuerttemberg is a state in southwest Germany with about 
11 million inhabitants and high participation in the primary care program. Analyses were based on routinely 
collected health data drawn from the administrative databases of the healthcare fund ‘Allgemeine Ortskrank-
enkasse’ (AOK) Baden-Wuerttemberg. AOK Baden-Wuerttemberg is the largest regional statutory health fund 
with > 40% coverage of the population. In 2017, more than 4000 GPs and 1.5 million patients were enrolled in the 
 programme35. The analysis was carried out as part of a broader evaluation of the program. The study followed the 
STROBE (Strengthening the Reporting of Observational Studies in Epidemiology)  guideline36 and the German 
standard for secondary data analysis (STROSA)37. The ethics committee of Frankfurt University Hospital (No. 
470/13) approved the study.
Study population. Patients were eligible to participate in the study, if they were insured by AOK in the year 
under observation (see Supplementary Fig. S9 online). Patients were excluded according to following predefined 
exclusion criteria: did not visit a GP, not continuously insured by AOK, < 18 years old, or participated in other 
healthcare programs, with the exception of nationwide DMPs for patients with chronic conditions. Participation 
in DMPs for diabetes, asthma, chronic obstructive pulmonary disease, and CHD were encouraged. In addi-
tion, we excluded patients if they did not participate in the program although their GP was participating, and 
participating patients with a non-participating GP. In the year under observation, patients were excluded if they 
or their GP switched groups, they changed their participating GP, they did not live in Baden-Wuerttemberg, 
or their GP practice was not located in Baden-Wuerttemberg. All inclusion and exclusion criteria were applied 
annually. In total, 3,056,472 patients were excluded of the study in 2011. Patients were assigned to the following 
disease cohorts based on the ICD codes of their diagnoses: diabetes mellitus type 2 (code E11), chronic heart 
failure (code I50), and coronary heart disease (codes I20-I25). Patients aged ≥ 65  years were assigned to the 
elderly cohort. The cohorts were not mutually exclusive. Patients in the intervention group had to be enrolled in 
the program and to provide written informed consent. Patients in the control group received usual primary care.
Primary care program. The primary care program is a structured, coordinated, and comprehensive pro-
gram. It seeks to improve care by strengthening the role of primary care. In comparison to other programs, 
which often focus on single-disease management or high-risk patients, the primary care program takes a pop-
ulation-based approach. It was arranged as a contract developed by health insurers in collaboration with GPs. 
Enrolment in the program is voluntary for both patients and GPs. The key elements of the program are struc-
tured management of chronic diseases, encouragement to participate in nationwide DMPs, coordinated access 
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to other medical specialists, continuous data-oriented quality improvement and peer-group trainings, comput-
erized decision support in prescribing medication, capitation-based reimbursement, and financial incentives to 
monitor patients with multiple chronic diseases. Since medication use is one of the risk factors for falls that is 
easy to modify, the program’s computerized decision support in prescribing medication would appear to be a 
promising approach to lowering the risk of falls among the  elderly38. Participating patients in the program had to 
select a participating GP for a fixed period of time, and to accept that medical specialist care was only available 
upon referral (except for emergencies, gynecologists, and ophthalmologists). Thus, specialist care was usually 
only provided to participants after referral by a GP. Participating patients benefit from shorter waiting times, less 
out-of-pocket expenditure for medications, and evening appointments. A detailed description of the program’s 
rationale and implementation have been reported  elsewhere14,20.
Measures. All data were recorded annually. The main outcome measure in this study was at least one hospi-
talization, specified as a dichotomous indicator. Hospitalization was defined as any hospital admission, including 
rehospitalization, that included at least one overnight stay in the year under observation. Hospitalizations were 
classified as all-cause, for ambulatory care-sensitive conditions, and subgroup-specific (three pre-defined sub-
groups for each cohort). We assessed hip fracture-related hospitalization as a subgroup-specific outcome in the 
elderly. Among the elderly, most hip fractures result from  falls39, and they are a leading cause of  hospitalisation38. 
Among diabetics, we specifically assessed diabetes-related hospitalization, and among CHF and CAD patients, 
hospitalization for cardiovascular disease. The following parameters were annually documented (see Supple-
mentary Table S1 online) and used for adjustment: patient age, gender, nursing care needs, rurality, group prac-
tice, health service utilization, and comorbid conditions. Comorbidity was also expressed using the Charlson 
 index40. Included variables were medically justified and based on availability in the administrative data. The 
outcome measures we used were similarly defined, based on previous  research20.
Data‑analysis. The characteristics of the participants at baseline are presented descriptively; Pearson’s chi-
square test and t-test were performed to detect differences between intervention and control group at the start 
of the study (Table 2).
To analyze the intervention effect, we used logistic regression models, adjusted for predetermined potential 
confounders (see Supplementary Table S1–13 online). Generalized estimation equations (GEE) were used to 
estimate the parameters of the model, taking into account inherent correlations in the subject caused by repeated 
measurement per subject. For the correlation we implied an autoregressive covariance structure. Odds ratios 
are calculated for the intervention group compared to the control group (intervention effect) at the beginning 
of the study and developments over time per year (time trend) in the control group. Additionally, an interac-
tion between intervention and time is included in the model. The interaction parameter provides information 
on whether the intervention effect increases or decreases over time. Thus, the odds ratio for the interaction 
parameter can be interpreted as the factor by which the trend in the intervention group increases or decreases 
compared to the trend in the control group. In addition to the odds ratios, confidence intervals and p-values were 
reported. The results of the model calculations are visualized in figures by displaying the proportions predicted 
by the model as a function of time. SAS version 9.4 and IBM SPSS Statistics (version 25) were used for statistical 
analysis. Figures were obtained using SAS version 9.4 (SAS Institute Inc., Cary, North Carolina, USA).
Data availability
AOK Baden-Wuerttemberg can be contacted for secondary analyses of their administrative data.
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